FindTrial
Sign In

Effect of rotigotine on the quality of recovery in patients with anesthesia awakening after DBS

Effect of rotigotine on the quality of recovery in patients with anesthesia awakening after DBS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057481
Enrollment
Unknown
Registered
2022-03-13
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease (PD)

Interventions

rotigotine group:rotigotine
control group:regular anti-Parkinson's drugs

Sponsors

First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Primary PD, or hereditary PD, responds well to compound levodopa; 2. Drug efficacy has been significantly decreased, or there are obvious sports complications affecting the quality of life of patients; 3. Adverse drug reactions that cannot be tolerated affect the efficacy of drugs; 4. The presence of tremors that cannot be controlled by medication.

Exclusion criteria

Exclusion criteria: 1. Patients with obvious cognitive dysfunction or hearing, reading, writing and language impairment before surgery. 2. Severe depression, anxiety, schizophrenia and other mental diseases. 3. Withdraw from the experimenter due to various emergencies. 4. Patients with intraoperative blood loss >800ml. 5. Patients with missing medical record data and poor treatment compliance.

Design outcomes

Primary

MeasureTime frame
Wake up time;Extubation time;Residence time in PACU;—

Secondary

MeasureTime frame
Muscle tension;Swallowing function;Salivary secretion;—

Countries

China

Contacts

Public ContactSong Guangdong

First Affiliated Hospital of Zhengzhou University

songyang_5223@163.com+86 18838049189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026